SMS Lifesciences Income Statement

Quarterly

Yearly

home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20212022
EBITDA3236
EBIT2439
Earning Per Share4483
Expenses235316
Net Profit1425
Net Profit Margin57
Operating Profit Margin1210
Profit Before Tax2033
Dividends Per Share22
Operation Revenue267352

Peer Comparison (in ₹.Cr.)

CompanyYearEBITEBITDANet ProfitNet WorthProfit Before Tax
202298.23103.1086.202,445.2397.80
20221,739.202,486.90993.609,042.131,441.20
2022-1,229.80428.90-1,509.7011,900.64-1,372.50
20223,086.904,252.102,112.2018,985.902,991.10
20224,608.6011,319.203,405.8047,771.294,481.30
The EBITDA of SMS Lifesciences is 36 as of 3/27/2023
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
2019202020212022
Operating Activities301535-11
Investing Activities-44-27-26-7
Financing Activities1512-311
Others0000
Net Cash Flow1-06-8

Peer Comparison (in ₹.Cr.)

CompanyYearOperating ActivitiesInvesting ActivitiesFinancing ActivitiesNet Cash Flow
2022-17.7518.85-5.82-4.72
20221,108.65-333.28-520.49254.88
2022367.311,292.23-1,572.3287.22
20163,262.60-2,039.40-1,700.10-476.90
20183,907.15-3,370.81-1,539.26-1,002.92
The cash flow from Operating Activities of SMS Lifesciences is -11 as of 3/27/2023